Role of connective tissue growth factor in extracellular matrix degradation in renal tubular epithelial cells

Abstract

In order to investigate the effects of connective tissue growth factor (CTGF) antisense oligodeoxynucleotide (ODN) on plasminogen activator inhibitor-1 (PAI-1) expression in renal tubular cells induced by transforming growth factor β1 (TGF-β1) and to explore the role of CTGF in the degradation of renal extracellular matrix (ECM), a human proximal tubular epithelial cell line (HKC) was cultured in vitro. Cationic lipid-mediated CTGF antisense ODN was transfected into HKC. After HKC were stimulated with TGF-β1 (5 μg/L), the mRNA level of PAI-1 was detected by RT-PCR. Intracellular PAI-1 protein synthesis was assessed by flow cytometry. The secreted PAI-1 in the media was determined by Western blot. The results showed that TGF-β1 could induce tubular CTGF and PAI-1 mRNA expression. The PAI-1 mRNA expression induced by TGF-β1 was significantly inhibited by CTGF antisense ODN. CTGF antisense ODN also inhibited intracellular PAI-1 protein synthesis and lowered the levels of PAI-1 protein secreted into the media. It was concluded that CTGF might play a crucial role in the degradation of excessive ECM during tubulointerstitial fibrosis, and blocking the biological effect of CTGF may be a novel way in preventing renal fibrosis.

Keywords

connective tissue growth factor / antisense oligodeoxynucleotide / plasminogen activator inhibitor-1 / renal tubular epithelial cells

References

[1] EddyA. A.. Molecular basis of renal fibrosis. Pediatric Nephrology, 2000, 15: 290-302

[2] HeidlandA., SebekovaK., PaczekL., et al.. Renal fibrosis: Role of impaired proteolysis and potential therapeutic strategies. Kidney Int Suppl, 1997, 62: s32-s35

[3] HanD. C., HoffmanB. B., HongS. W., et al.. Therapy with antisense TGF-beta 1 oligodeoxynucleotides reduces kidney weight and matrix mRNA in diabetic mice. Am J Physiol Renal Physiol, 2000, 278: F628-634

[4] HuangH. C., MinY. L., LiJ. Z., et al.. Comparative effect between Astrogalus-Angelica mixture and enalapril on expression of connective tissue growth factor in rats with renal tubulointerstitial fibrosis. Chin J Nephrol (Chinese), 2003, 19: 133-136

[5] BradhamD. M., IgarashiA., PotterR. I., et al.. Connective tissue growth factor: a cystein-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol, 1991, 114: 1285-1294

[6] ItoY., AtenJ., BendeR. J., et al.. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int, 1998, 53: 853-861

[7] GrotendorstG. R., OkochiH., HagashN., et al.. A novel transforming growth factor β response element controls the expression of connective tissue growth factor gene. Cell Growth Differ, 1996, 7: 469-480

[8] YokoiH., MukoyamaM., SugawaraA., et al.. Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis. Am J Physiol Renal Physiol, 2002, 282: F933-F942

[9] BadidC., VincentM., FouqueD., et al.. Myofibroblast: a prognostic marker and target cell in progressive renal disease. Renal Fail, 2001, 23: 543-549

[10] WangS., DenichiloM., BrubakerC., et al.. Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy. Kidney Int, 2001, 60: 96-105

[11] WangS., HirschbergR.. BMP7 antagnized TGF-β-dependent fibrogenesis in mesangial cells. Am J Physiol Renal Physiol, 2003, 284: F1006-F1013